CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer

作者: Sayantan Bhattacharyya , Vasanthakumar Sekar , Biswanath Majumder , Debapriya G Mehrotra , Samir Banerjee

DOI: 10.1007/S13402-016-0311-7

关键词:

摘要: The tumor suppressor protein p53 is known to control cell cycle arrest and apoptosis. Lupeol a phytochemical that has been found induce apoptosis in different cancer types through the extrinsic pathway. As yet, however, its role induction of intrinsic pathway head neck not investigated. Here, we aimed at understanding mechanism underlying antitumor effect cancer. on oral laryngeal carcinomas was assessed using two vitro 2D line models (HEp-2, UPCI:SCC-131) and, subsequently, an ex vivo 3D explant culture platform maintains key features native microenvironment. Lupeol-mediated responses delineated MTT, colony formation, flow cytometry, immunofluorescence, Western blotting immunohistochemistry assays. We induced enhanced expression both tested G1 phase. In addition that, following treatment, Bax activated apoptotic (as measured by Caspase-3 cleavage). Interestingly, also trigger up-regulation CDKN2A, but p21, resulting inhibition CyclinD1. impart potent response as defined Ki67 expression, decreased viability concomitant activation (cleavage) Caspase-3. Finally, can re-sensitize primary squamous carcinoma (HNSCC) samples had clinically progressed under Cisplatin treatment regimen. Together, our data indicate may orchestrate bifurcated regulation neoplastic growth cancers serve promising agent for management tumors have platinum-based

参考文章(60)
Dita Královcová, Marcela Pejchalová, Emil Rudolf, Miroslav Červinka, Quantitative analysis of expression level of BCL2 and BAX genes in Hep-2 and HL-60 cells after treatment with etoposide. Acta Medica (Hradec Kralove, Czech Republic). ,vol. 51, pp. 191- 195 ,(2008) , 10.14712/18059694.2017.23
AJ Minn, CM Rudin, LH Boise, CB Thompson, Expression of Bcl-xL Can Confer a Multidrug Resistance Phenotype Blood. ,vol. 86, pp. 1903- 1910 ,(1995) , 10.1182/BLOOD.V86.5.1903.BLOODJOURNAL8651903
Michael O Hengartner, Apoptosis: corralling the corpses. Cell. ,vol. 104, pp. 325- 328 ,(2001) , 10.1016/S0092-8674(01)00219-7
Ralph Hoessel, Sophie Leclerc, Jane A. Endicott, Martin E. M. Nobel, Alison Lawrie, Paul Tunnah, Maryse Leost, Eve Damiens, Dominique Marie, Doris Marko, Ellen Niederberger, Weici Tang, Gerhard Eisenbrand, Laurent Meijer, Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases Nature Cell Biology. ,vol. 1, pp. 60- 67 ,(1999) , 10.1038/9035
Milena Gasco, Shukri Shami, Tim Crook, The p53 pathway in breast cancer Breast Cancer Research. ,vol. 4, pp. 70- 76 ,(2002) , 10.1186/BCR426
Hala Gali-Muhtasib, Raed Hmadi, Mike Kareh, Rita Tohme, Nadine Darwiche, Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis Apoptosis. ,vol. 20, pp. 1531- 1562 ,(2015) , 10.1007/S10495-015-1169-2
Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, Padhma Radhakrishnan, Harikrishna Narasimhan, Muthu Dhandapani, Nilesh Brijwani, Dency D. Pinto, Arun Prasath, Basavaraja U. Shanthappa, Allen Thayakumar, Rajagopalan Surendran, Govind K. Babu, Ashok M. Shenoy, Moni A. Kuriakose, Guillaume Bergthold, Peleg Horowitz, Massimo Loda, Rameen Beroukhim, Shivani Agarwal, Shiladitya Sengupta, Mallikarjun Sundaram, Pradip K. Majumder, Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity Nature Communications. ,vol. 6, pp. 6169- 6169 ,(2015) , 10.1038/NCOMMS7169
Qian Huang, Fang Li, Xinjian Liu, Wenrong Li, Wei Shi, Fei-Fei Liu, Brian O'Sullivan, Zhimin He, Yuanlin Peng, Aik-Choon Tan, Ling Zhou, Jingping Shen, Gangwen Han, Xiao-Jing Wang, Jackie Thorburn, Andrew Thorburn, Antonio Jimeno, David Raben, Joel S Bedford, Chuan-Yuan Li, Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy Nature Medicine. ,vol. 17, pp. 860- 866 ,(2011) , 10.1038/NM.2385
H. Igaki, H. Sasaki, T. Kishi, H. Sakamoto, Y. Tachimori, H. Kato, H. Watanabe, T. Sugimura, M. Terada, Highly Frequent Homozygous Deletion of the p16 Gene in Esophageal Cancer Cell Lines Biochemical and Biophysical Research Communications. ,vol. 203, pp. 1090- 1095 ,(1994) , 10.1006/BBRC.1994.2294